SEAN PARKER: Open Payments
NPI 1295819811 · THOMASTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 99 payments from 19 companies in 2025. Trend: 2023 $1,669 · 2024 $1,839 · 2025 $1,703
Food & beverage: $1,703
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 29 | $371 |
| PFIZER INC. | 21 | $370 |
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| Lilly USA, LLC | 11 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $127 |
| ABBVIE INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Amgen Inc. | 4 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
Products named: Ozempic, NURTEC ODT, Rybelsus, FANAPT, MOUNJARO, FARXIGA, PREVNAR 20, ELIQUIS.
Industry payments across GA — which companies pay providers there.
